New Formulation of Traconazole Approved for Certain Systemic Fungal Infections
December 13th 2018SUBA-itraconazole is indicated for the treatment of blastomycosis, pulmonary and extrapulmonary; histoplasmosis, including chronic cavitary pulmonary disease and disseminated, nonmeningeal histoplasmosis; and aspergillosis, pulmonary and extrapulmonary.
Read More
Study Highlights Challenges with Lipid-Lowering Therapies Despite Efficacy
December 13th 2018New study data reinforce the long-term efficacy and safety of Amgen’s evolocumab (Repatha) in individuals at risk for heart attack and stroke, but an additional analysis highlights challenges associated with use of lipid-lowering therapies (LLTs) in these patients.
Read More